Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel

Infliximab is an effective treatment for sarcoidosis patients with persistent disease despite glucocorticoids and immunosuppressive therapy. Patients receiving infliximab can experience side effects, inducing an autoimmune reaction. Treatment is unclear for sarcoidosis patients who develop autoimmun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Ying, Lower, Elyse E., Li, Huiping, Baughman, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821248/
https://www.ncbi.nlm.nih.gov/pubmed/27222775
http://dx.doi.org/10.1016/j.rmcr.2015.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4821248/
https://www.ncbi.nlm.nih.gov/pubmed/27222775
http://dx.doi.org/10.1016/j.rmcr.2015.11.001

Ejemplares similares